JPMorgan says any equity market weakness should be bought By Investing.com

JPMorgan says the recent Middle East-driven sell-off is a buying opportunity, arguing that rate-hike pricing is unwarranted with the Fed on hold at 3.75% and wage growth near 4%. The bank remains constructive on equities, seeing 2026 EPS growth of about 19% for MSCI Eurozone, 45% for emerging markets, and 20% for the S&P 500, with broader leadership beyond the Magnificent 7. It also favors emerging markets on a 38% forward P/E discount to developed markets, improving fundamentals, and light positioning.

Analysis

The first-order signal is not simply “buy stocks on the dip,” but that geopolitical risk is being misclassified by the market as an inflation problem rather than a growth shock. That matters because a growth shock with contained wage pressure tends to compress real rates and steepen the path to easing, which is a cleaner setup for equities than the 2022 regime of sticky inflation and forced tightening. The likely beneficiaries are duration-sensitive equities and non-US cyclicals where even a modest decline in yields and dollar softness can re-rate multiples faster than earnings revise up.

The more interesting second-order effect is leadership breadth. If semis and mega-cap AI remain supported but no longer monopolize marginal flows, the next leg should favor cheaper beta with operating leverage: small caps, financials, industrials, and EM cyclicals. That creates a relative trade against crowded US growth and into regions where positioning is still light; the valuation gap implies less good news is needed for EM to outperform if the dollar resumes weakening and global yields drift lower.

The main risk is that the market is underpricing the persistence of headline-driven volatility over the next 2-6 weeks. A short, sharp escalation that spikes energy and shipping costs could temporarily reflate inflation expectations and hit cyclicals before policy relief arrives. Conversely, if the conflict de-escalates quickly, the argument for lower yields and broader risk-on broadens further, but the trade becomes more crowded, so entry discipline matters more than macro conviction.

The contrarian read is that consensus may be too anchored to last year’s narrow AI trade and too slow to rotate into laggards that have already de-risked. JPMorgan’s own bias toward equities could be right, but the more attractive expression is likely not outright beta; it is a barbell of quality growth plus undervalued cyclicals, financed by shorts in expensive, momentum-sensitive beneficiaries that depend on falling rates but already embed perfection.

Key Decisions for Investors

• Go long EEM or IEMG for a 1-3 month horizon versus short SPY or IWM as a relative value expression; thesis is dollar weakness plus lower yields should lift EM beta faster than US indices re-rate, with ~5-10% upside if breadth rotates as expected.
• Add to semis via SMH / long SMCI on weakness, but hedge with a short in QQQ or a call spread to avoid paying full premium for the AI crowding trade; keep horizon to 4-8 weeks because the upside is continuation, not new leadership.
• Initiate a pair trade: long XLF or regional banks versus short high-duration software names over 2-4 months; if rates drift lower without recession, financials gain from curve normalization while software de-rates less favorably than the market expects.
• Buy small caps through IWM only on a market pullback, with a tight risk stop if yields re-spike; the setup is a 1.5-2.0x upside to downside asymmetry if geopolitical headlines fade and the dollar weakens, but it is fragile to any renewed oil shock.
• Use call spreads rather than outright longs in JPM, SMCI, or APP: JPM for a defensive beneficiaries basket if equity weakness is bought, SMCI/APP only as momentum satellites because their upside is already partially priced and they are vulnerable to any reversal in risk appetite.